Saviola G - Search Results

1

Efficacy and safety of leflunomide or methotrexate plus subcutaneous tumour necrosis factor-alpha blocking agents in rheumatoid arthritis.

Benucci M, Saviola G, Baiardi P, Manfredi M, Sarzi-Puttini P, Atzeni F. Benucci M, et al. Among authors: saviola g. Int J Immunopathol Pharmacol. 2011 Jan-Mar;24(1):269-74. doi: 10.1177/039463201102400136. Int J Immunopathol Pharmacol. 2011. PMID: 21496415 Free article. Clinical Trial.

2

The economic burden of biological therapy in rheumatoid arthritis in clinical practice: cost-effectiveness analysis of sub-cutaneous anti-TNFalpha treatment in Italian patients.

Benucci M, Li Gobbi F, Sabadini L, Saviola G, Baiardi P, Manfredi M. Benucci M, et al. Among authors: saviola g. Int J Immunopathol Pharmacol. 2009 Oct-Dec;22(4):1147-52. doi: 10.1177/039463200902200434. Int J Immunopathol Pharmacol. 2009. PMID: 20074482 Free article.

3

Anti-nucleosome antibodies as prediction factor of development of autoantibodies during therapy with three different TNFalpha blocking agents in rheumatoid arthritis.

Benucci M, Saviola G, Baiardi P, Cammelli E, Manfredi M. Benucci M, et al. Among authors: saviola g. Clin Rheumatol. 2008 Jan;27(1):91-5. doi: 10.1007/s10067-007-0728-5. Epub 2007 Oct 10. Clin Rheumatol. 2008. PMID: 17929076

4

Improved rheumatoid digital vasculitis in a patient treated with TNFalpha agent blocking (infliximab).

Benucci M, Li Gobbi F, Saviola G, Manfredi M. Benucci M, et al. Among authors: saviola g. Rheumatol Int. 2008 Oct;28(12):1253-5. doi: 10.1007/s00296-008-0592-x. Epub 2008 May 21. Rheumatol Int. 2008. PMID: 18493770

5

Tumor necrosis factors blocking agents: analogies and differences.

Benucci M, Saviola G, Manfredi M, Sarzi-Puttini P, Atzeni F. Benucci M, et al. Among authors: saviola g. Acta Biomed. 2012 Apr;83(1):72-80. Acta Biomed. 2012. PMID: 22978063 Review.

6

Clarithromycin in rheumatoid arthritis: the addition to methotrexate and low-dose methylprednisolone induces a significant additive value--a 24-month single-blind pilot study.

Saviola G, Abdi-Ali L, Campostrini L, Sacco S, Baiardi P, Manfredi M, Benucci M, Bucci M, Cirino G. Saviola G, et al. Rheumatol Int. 2013 Nov;33(11):2833-8. doi: 10.1007/s00296-013-2822-0. Epub 2013 Jul 18. Rheumatol Int. 2013. PMID: 23864141 Clinical Trial.

7

Correlation between atopy and hypersensitivity reactions during therapy with three different TNF-alpha blocking agents in rheumatoid arthritis.

Benucci M, Manfredi M, Saviola G, Baiardi P, Campi P. Benucci M, et al. Among authors: saviola g. Clin Exp Rheumatol. 2009 Mar-Apr;27(2):333-6. Clin Exp Rheumatol. 2009. PMID: 19473578

8

Determinants of Risk Infection During Therapy with Anti TNF-Alpha Blocking Agents in Rheumatoid Arthritis.

Benucci M, Saviola G, Baiardi P, Manfredi M, Sarzi Puttini P, Atzeni F. Benucci M, et al. Among authors: saviola g. Open Rheumatol J. 2012;6:33-7. doi: 10.2174/1874312901206010033. Epub 2012 Apr 24. Open Rheumatol J. 2012. PMID: 22655000 Free PMC article.

9

Cost-effectiveness treatment with Rituximab in patients with rheumatoid arthritis in real life.

Benucci M, Saviola G, Baiardi P, Manfredi M. Benucci M, et al. Among authors: saviola g. Rheumatol Int. 2011 Nov;31(11):1465-9. doi: 10.1007/s00296-010-1502-6. Epub 2010 May 16. Rheumatol Int. 2011. PMID: 20473760

10

Cost effectiveness analysis of disease-modifying antirheumatic drugs in rheumatoid arthritis. A systematic review literature.

Benucci M, Saviola G, Manfredi M, Sarzi-Puttini P, Atzeni F. Benucci M, et al. Among authors: saviola g. Int J Rheumatol. 2011;2011:845496. doi: 10.1155/2011/845496. Epub 2011 Nov 22. Int J Rheumatol. 2011. PMID: 22162693 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters